Lexaria Bioscience (LEXX) Institutional Ownership → What is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (From Weiss Ratings) (Ad) Free LEXX Stock Alerts $3.89 -0.10 (-2.51%) (As of 05/31/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Lexaria Bioscience (NASDAQ:LEXX)CurrentInstitutional OwnershipPercentage13.06%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$1.51MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$979.58K Get LEXX Insider Trade Alerts Want to know when executives and insiders are buying or selling Lexaria Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LEXX Institutional Buying and Selling by Quarter Ad Weiss RatingsWhat is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners”A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are. Lexaria Bioscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2024 Invenomic Capital Management LP473,265$1.72M0.1%-35.3%3.672% 4/9/2024 Welch Group LLC24,000$87K0.0%N/A0.194% 2/14/2024 Invenomic Capital Management LP731,981$915K0.0%-4.2%7.011% 2/8/2024 Cowen AND Company LLC256,327$320K0.1%N/A2.455% 11/15/2023 Armistice Capital LLC889,272$889K0.0%N/A10.992% 8/14/2023 Invenomic Capital Management LP766,573$560K0.0%+62.0%9.476% 8/8/2022 Merit Financial Group LLC21,267$63K0.0%N/A0.357% 2/11/2022 Invenomic Capital Management LP359,113$1.45M0.3%+1.9%6.034% 11/15/2021MD Financial Management Inc.407,687$2.55M0.1%+15,078.2%7.988% 8/16/2021 Invenomic Capital Management LP317,110$2.22M0.5%+7.1%6.213% 8/13/2021 Renaissance Technologies LLC17,200$120K0.0%N/A0.337% 8/13/2021 Geode Capital Management LLC50,385$352K0.0%N/A0.987% 8/13/2021 Vanguard Group Inc.25,976$182K0.0%N/A0.509% 5/21/2021 Citadel Advisors LLC14,915$84K0.0%N/A0.292% 5/18/2021 Citadel Advisors LLC14,915$84K0.0%N/A0.292% (Data available from 1/1/2016 forward) LEXX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LEXX shares? During the previous two years, the following institutional investors and hedge funds held shares of Lexaria Bioscience shares: Invenomic Capital Management LP ($1.72M), Armistice Capital LLC ($889K), Cowen AND Company LLC ($320K), and Welch Group LLC ($87K), Merit Financial Group LLC ($63K).Learn more on LEXX's institutional investors. What percentage of Lexaria Bioscience stock is owned by institutional investors? 13.06% of Lexaria Bioscience stock is owned by institutional investors. Learn more on LEXX's institutional investor holdings. Which institutional investors have been buying Lexaria Bioscience stock? The following institutional investors have purchased Lexaria Bioscience stock in the last 24 months: Armistice Capital LLC ($889.27K), Invenomic Capital Management LP ($293.47K), Cowen AND Company LLC ($256.33K), Welch Group LLC ($24K), and Merit Financial Group LLC ($21.27K). How much institutional buying is happening at Lexaria Bioscience? Institutional investors have bought a total of 1,484,336 shares in the last 24 months. This purchase volume represents approximately $1.57M in transactions. Which Lexaria Bioscience major shareholders have been selling company stock? The following institutional investors have sold Lexaria Bioscience stock in the last 24 months: Invenomic Capital Management LP ($291.07K). How much institutional selling is happening at Lexaria Bioscience? Institutional investors have sold a total of 291,067 shares in the last 24 months. This volume of shares sold represents approximately $979.58K in transactions. Related Companies: GLSI Institutional Ownership LFCR Institutional Ownership ABEO Institutional Ownership ALIM Institutional Ownership RIGL Institutional Ownership VERU Institutional Ownership SGMT Institutional Ownership CNTX Institutional Ownership RNAC Institutional Ownership PRQR Institutional Ownership This page (NASDAQ:LEXX) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexaria Bioscience Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.